- Home
- ELDN vs ZYBT Comparison
ELDN vs ZYBT Comparison
Compare ELDN & ZYBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- ZYBT
- Stock Information
- Founded
- ELDN 2004
- ZYBT 2004
- Country
- ELDN United States
- ZYBT China
- Employees
- ELDN N/A
- ZYBT N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- ZYBT
- Sector
- ELDN Health Care
- ZYBT
- Exchange
- ELDN Nasdaq
- ZYBT NYSE
- Market Cap
- ELDN 232.4M
- ZYBT 206.2M
- IPO Year
- ELDN N/A
- ZYBT 2025
- Fundamental
- Price
- ELDN $3.22
- ZYBT $5.32
- Analyst Decision
- ELDN Strong Buy
- ZYBT
- Analyst Count
- ELDN 1
- ZYBT 0
- Target Price
- ELDN $16.00
- ZYBT N/A
- AVG Volume (30 Days)
- ELDN 261.7K
- ZYBT 306.4K
- Earning Date
- ELDN 05-08-2025
- ZYBT 01-01-0001
- Dividend Yield
- ELDN N/A
- ZYBT N/A
- EPS Growth
- ELDN N/A
- ZYBT N/A
- EPS
- ELDN N/A
- ZYBT 0.06
- Revenue
- ELDN N/A
- ZYBT $26,111,272.00
- Revenue This Year
- ELDN N/A
- ZYBT N/A
- Revenue Next Year
- ELDN N/A
- ZYBT N/A
- P/E Ratio
- ELDN N/A
- ZYBT $88.01
- Revenue Growth
- ELDN N/A
- ZYBT N/A
- 52 Week Low
- ELDN $1.52
- ZYBT $3.70
- 52 Week High
- ELDN $5.54
- ZYBT $10.00
- Technical
- Relative Strength Index (RSI)
- ELDN 30.78
- ZYBT N/A
- Support Level
- ELDN $3.22
- ZYBT N/A
- Resistance Level
- ELDN $3.45
- ZYBT N/A
- Average True Range (ATR)
- ELDN 0.19
- ZYBT 0.00
- MACD
- ELDN -0.01
- ZYBT 0.00
- Stochastic Oscillator
- ELDN 7.01
- ZYBT 0.00
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About ZYBT ZHENGYE BIOTECHNOLOGY HLDG LTD
Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs and is available in 29 provincial regions across China and are exported overseas to Vietnam, Pakistan and Egypt.